$245 Million is the total value of Altium Capital Management LP's 68 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 67.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VERA | Buy | VERA THERAPEUTICS INCcl a | $25,832,520 | -15.6% | 714,000 | +0.6% | 10.54% | -13.0% |
| ADMA | Sell | ADMA BIOLOGICS INC | $16,881,800 | +66.1% | 1,510,000 | -1.9% | 6.89% | +71.2% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $14,059,794 | -6.2% | 360,600 | +3.6% | 5.74% | -3.3% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $13,218,570 | +69.0% | 193,000 | +70.8% | 5.39% | +74.2% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $12,940,200 | – | 81,900 | +100.0% | 5.28% | – |
| INSM | Buy | INSMED INC | $12,730,000 | +291.0% | 190,000 | +58.3% | 5.19% | +303.2% |
| Sell | ALIMERA SCIENCES INC | $11,954,000 | +20.2% | 2,150,000 | -15.7% | 4.88% | +23.9% | |
| New | SKYE BIOSCIENCE INC | $10,814,245 | – | 1,350,093 | +100.0% | 4.41% | – | |
| ARGX | New | ARGENX SEsponsored adr | $9,890,920 | – | 23,000 | +100.0% | 4.04% | – |
| Buy | SOLENO THERAPEUTICS INC | $8,686,687 | +32.7% | 212,909 | +39.2% | 3.54% | +36.8% | |
| New | AVADEL PHARMACEUTICALS PLC | $8,576,600 | – | 610,000 | +100.0% | 3.50% | – | |
| CPRX | CATALYST PHARMACEUTICALS INC | $7,745,000 | -2.8% | 500,000 | 0.0% | 3.16% | +0.2% | |
| New | CONTINEUM THERAPEUTICS INCcl a | $7,560,677 | – | 429,340 | +100.0% | 3.08% | – | |
| RZLT | New | REZOLUTE INC | $7,310,000 | – | 1,700,000 | +100.0% | 2.98% | – |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $6,819,000 | +80.4% | 50,000 | +100.0% | 2.78% | +86.0% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $6,467,220 | -7.2% | 122,000 | +43.5% | 2.64% | -4.4% |
| SVRA | Buy | SAVARA INC | $6,347,250 | -4.5% | 1,575,000 | +18.0% | 2.59% | -1.6% |
| KMPH | Buy | ZEVRA THERAPEUTICS INC | $5,695,838 | +187.6% | 1,162,416 | +240.4% | 2.32% | +196.4% |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $5,056,550 | – | 115,000 | +100.0% | 2.06% | – | |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $5,024,250 | -4.8% | 693,000 | -0.3% | 2.05% | -1.8% |
| XTNT | Sell | XTANT MED HLDGS INC | $4,671,711 | -47.8% | 7,415,413 | -3.0% | 1.91% | -46.2% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $4,025,000 | -63.5% | 50,000 | -63.8% | 1.64% | -62.3% |
| REAL | Buy | THE REALREAL INC | $3,988,259 | +27.5% | 1,250,238 | +56.3% | 1.63% | +31.4% |
| CLXPF | CYBIN INC | $3,781,395 | -34.5% | 13,953,488 | 0.0% | 1.54% | -32.4% | |
| New | OUTLOOK THERAPEUTICS INC | $3,703,173 | – | 501,785 | +100.0% | 1.51% | – | |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $2,877,000 | – | 70,000 | +100.0% | 1.17% | – |
| ORIC | ORIC PHARMACEUTICALS INC | $2,863,350 | -48.6% | 405,000 | 0.0% | 1.17% | -47.0% | |
| VERU | Buy | VERU INC | $1,915,381 | +29.6% | 2,276,692 | +7.8% | 0.78% | +33.5% |
| New | PERSPECTIVE THERAPEUTICS INC | $1,908,757 | – | 191,450 | +100.0% | 0.78% | – | |
| LRMR | New | LARIMAR THERAPEUTICS INCcall | $1,421,000 | – | 196,000 | +100.0% | 0.58% | – |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $1,336,326 | -38.4% | 1,012,368 | -16.5% | 0.54% | -36.6% |
| Sell | ACHIEVE LIFE SCIENCES INC | $1,016,657 | -73.2% | 216,310 | -74.1% | 0.42% | -72.4% | |
| New | ALLURION TECHNOLOGIES INC | $967,512 | – | 969,840 | +100.0% | 0.40% | – | |
| ANVS | New | ANNOVIS BIO INCput | $894,528 | – | 155,300 | +100.0% | 0.36% | – |
| BIVI | Sell | BIOVIE INCcl a new | $793,928 | -50.1% | 1,982,341 | -34.2% | 0.32% | -48.6% |
| New | CONTEXT THERAPEUTICS INC | $721,802 | – | 360,001 | +100.0% | 0.29% | – | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $642,024 | -42.5% | 740,000 | 0.0% | 0.26% | -40.7% | |
| RAPT | New | RAPT THERAPEUTICS INCcall | $610,000 | – | 200,000 | +100.0% | 0.25% | – |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $569,000 | -41.6% | 200,000 | 0.0% | 0.23% | -39.7% | |
| New | APREA THERAPEUTICS INC | $558,392 | – | 137,197 | +100.0% | 0.23% | – | |
| SPRB | Sell | SPRUCE BIOSCIENCES INC | $419,941 | -53.5% | 811,167 | -29.5% | 0.17% | -52.2% |
| Sell | EVOKE PHARMA INC | $366,301 | -17.2% | 692,440 | -4.5% | 0.15% | -14.9% | |
| Sell | BOUNDLESS BIO INC | $321,787 | -88.7% | 83,149 | -58.4% | 0.13% | -88.4% | |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $204,936 | – | 121,986 | +100.0% | 0.08% | – |
| New | INTELLIGENT BIO SOLUTIONS IN | $161,100 | – | 83,906 | +100.0% | 0.07% | – | |
| Sell | PERFECT MOMENT LTD | $135,095 | -59.1% | 62,835 | -31.9% | 0.06% | -58.0% | |
| NEXGEL INC*w exp 12/01/202 | $98,325 | -39.3% | 225,000 | 0.0% | 0.04% | -37.5% | ||
| SVRA | New | SAVARA INCcall | $80,600 | – | 20,000 | +100.0% | 0.03% | – |
| New | CEMTREX INC | $74,791 | – | 339,961 | +100.0% | 0.03% | – | |
| WEARABLE DEVICES LTD*w exp 09/14/202 | $70,015 | -36.0% | 1,411,600 | 0.0% | 0.03% | -32.6% | ||
| Buy | QUOIN PHARMACEUTICALS LTDsponsored ads | $59,814 | -4.9% | 103,127 | +55.7% | 0.02% | -4.0% | |
| ONFOLIO HOLDINGS INC*w exp 01/02/202 | $49,760 | +512.8% | 200,000 | 0.0% | 0.02% | +566.7% | ||
| ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $44,406 | -79.7% | 731,561 | 0.0% | 0.02% | -79.3% | ||
| NEXALIN TECHNOLOGY INC*w exp 99/99/999 | $35,700 | +713.4% | 105,000 | 0.0% | 0.02% | +650.0% | ||
| New | APPLIED DNA SCIENCES INC | $35,184 | – | 86,152 | +100.0% | 0.01% | – | |
| New | VSEE HEALTH INC*w exp 99/99/999 | $32,460 | – | 150,000 | +100.0% | 0.01% | – | |
| MOBIX LABS INC*w exp 99/99/999 | $26,820 | -14.9% | 150,000 | 0.0% | 0.01% | -8.3% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 02/02/202 | $6,900 | +0.3% | 200,000 | 0.0% | 0.00% | 0.0% | |
| CEA INDUSTRIES INC*w exp 02/11/202 | $3,750 | +15.4% | 250,000 | 0.0% | 0.00% | +100.0% | ||
| WESTERN ACQSTN VENTURES CORP*w exp 99/99/999 | $3,660 | -14.4% | 100,000 | 0.0% | 0.00% | -50.0% | ||
| JEFFS BRANDS LTD*w exp 99/99/999 | $2,198 | -45.2% | 68,681 | 0.0% | 0.00% | -50.0% | ||
| CONDUIT PHARMACEUTICALS INC*w exp 09/22/202 | $1,550 | -74.2% | 100,000 | 0.0% | 0.00% | -50.0% | ||
| CINGULATE INC*w exp 12/10/202 | $2,916 | -48.8% | 270,000 | 0.0% | 0.00% | -50.0% | ||
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $1,417 | -24.2% | 28,333 | 0.0% | 0.00% | 0.0% | ||
| BITCOIN DEPOT INC*w exp 06/30/202 | $2,365 | -50.2% | 50,000 | 0.0% | 0.00% | -50.0% | ||
| SURROZEN INC*w exp 08/01/203 | $1,365 | -59.9% | 82,233 | 0.0% | 0.00% | 0.0% | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/10/202 | $235 | -37.5% | 18,823 | 0.0% | 0.00% | – | ||
| SELINA HOSPITALITY PLC*w exp 10/27/202 | $1,101 | +55.1% | 101,439 | 0.0% | 0.00% | – | ||
| Exit | RELATIVITY ACQUISITION CORP*w exp 12/15/202 | $0 | – | -100,000 | -100.0% | 0.00% | – | |
| Exit | BRUUSH ORAL CARE INC*w exp 08/03/202 | $0 | – | -14,423 | -100.0% | 0.00% | – | |
| Exit | PROSOMNUS INC*w exp 04/20/202 | $0 | – | -150,000 | -100.0% | -0.00% | – | |
| Exit | DIGITAL HEALTH ACQUISITION C*w exp 99/99/999 | $0 | – | -150,000 | -100.0% | -0.01% | – | |
| MBTCR | Exit | NOCTURNE ACQUISITION CORPright 12/26/2025 | $0 | – | -500,000 | -100.0% | -0.03% | – |
| Exit | AZITRA INC | $0 | – | -493,153 | -100.0% | -0.04% | – | |
| Exit | GRI BIO INC | $0 | – | -187,981 | -100.0% | -0.06% | – | |
| Exit | MOBILICOM LTDspon ads | $0 | – | -135,292 | -100.0% | -0.06% | – | |
| ISR | Exit | PERSPECTIVE THERAPEUTICS INC | $0 | – | -535,657 | -100.0% | -0.25% | – |
| Exit | GERON CORPcall | $0 | – | -400,000 | -100.0% | -0.52% | – | |
| Exit | TOURMALINE BIO INC | $0 | – | -65,442 | -100.0% | -0.59% | – | |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -176,840 | -100.0% | -0.63% | – | |
| Exit | RAPT THERAPEUTICS INCcall | $0 | – | -200,000 | -100.0% | -0.71% | – | |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -142,532 | -100.0% | -0.79% | – | |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -57,271 | -100.0% | -0.98% | – |
| AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -665,000 | -100.0% | -1.12% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -77,848 | -100.0% | -1.22% | – |
| LBPH | Exit | LONGBOARD PHARMACEUTICALS IN | $0 | – | -170,000 | -100.0% | -1.45% | – |
| Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -78,100 | -100.0% | -1.89% | – | |
| Exit | NEUROGENE INC | $0 | – | -100,000 | -100.0% | -2.01% | – | |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -208,000 | -100.0% | -2.07% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -605,000 | -100.0% | -2.71% | – |
| Exit | BIOHAVEN LTD | $0 | – | -140,000 | -100.0% | -3.03% | – | |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -553,057 | -100.0% | -3.70% | – |
| Exit | ADVISORSHARES TRcall | $0 | – | -1,125,000 | -100.0% | -4.46% | – | |
| Exit | VIKING THERAPEUTICS INCput | $0 | – | -175,300 | -100.0% | -5.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 15 | Q2 2024 | 0.6% |
| XTANT MED HLDGS INC | 13 | Q2 2024 | 6.2% |
| SURROZEN INC | 12 | Q2 2024 | 0.0% |
| ADMA BIOLOGICS INC | 11 | Q2 2024 | 6.9% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| INSMED INC | 11 | Q2 2024 | 5.2% |
| NEXGEL INC | 11 | Q2 2024 | 0.1% |
| NOCTURNE ACQUISITION CORP | 11 | Q1 2024 | 0.1% |
| CINGULATE INC | 11 | Q2 2024 | 0.1% |
| NLS PHARMACEUTICS LTD | 11 | Q2 2024 | 0.0% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CEMTREX INC | May 08, 2024 | 36,984 | 10.0% |
| Sunshine Biopharma, Inc | February 21, 2024 | 3,727,984 | 10.0% |
| Evoke Pharma Inc | February 20, 2024 | 822,986 | 9.7% |
| ALIMERA SCIENCES INC | February 13, 2024 | 2,660,000 | 5.0% |
| Cyclacel Pharmaceuticals, Inc. | February 13, 2024 | 37,982 | 5.0% |
| GRI BIO, Inc. | February 13, 2024 | 1,269,210 | 5.0% |
| Marpai, Inc.Sold out | February 13, 2024 | 0 | 0.0% |
| NovaBay Pharmaceuticals, Inc. | February 13, 2024 | 67,457 | 5.0% |
| Volcon, Inc. | February 13, 2024 | 1,666,665 | 9.9% |
| Xtant Medical Holdings, Inc. | February 13, 2024 | 8,027,593 | 6.2% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-09-26 |
| N-PX | 2024-08-26 |
| SC 13G | 2024-08-16 |
| 13F-HR | 2024-08-15 |
| SC 13G | 2024-08-09 |
| SC 13G | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-08 |
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.